E-ISSN 2146-9369 | ISSN 2146-3158
 
2024, Vol: 14, Issue: 3
14 / 3Current Issue ArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles

Research Article 


In Vitro Activities of Ceftazidime-avibactam and Comparator Antimicrobial Agents Tested against ESBL Producing Urinary E. coli Isolates

Estelle Caine, Ozlem Koyuncu Ozyurt, Gozde Ongut, Kubra Kasaroglu, Emre Yıldız, Dilara Ogunc, Filiz Gunseren, Dilek Colak, Ozge Turhan, Betil Ozhak.


Cited By:3

Abstract
Objectives: Urinary tract infections (UTIs) remain one of the most common infections for antibiotic prescription. Increased resistance to antibiotics currently used to treat these infections may lead to significant problems. Extended spectrum beta-lactamase (ESBL) production in organisms causing UTIs are often responsible for the increase in resistance. The aim of this study was to investigate the in vitro antimicrobial susceptibility of ESBL producing community acquired urinary E. coli isolates to Ceftazidime/Avibactam (CAZ/AVI) and other antimicrobial agents using disk diffusion method.
Methods: Between 2016 and 2017, a total of 100 ESBL producing E. coli urine isolates were collected from outpatients who had no history of hospitalization in the last three months in Akdeniz University Hospital. All isolates were tested for in vitro susceptibility to the CAZ/AVI and other antimicrobial agents using disk diffusion method. Results: No CAZ/AVI and carbapenem resistance were observed. Resistance rates to other antimicrobial agents were as follows: ampicillin 100%, amoxicillin/clavulanate 85%, cefotaxime 98%, ceftazidime 89%, cefepime 82%, gentamicin 41%, ciprofloxacin 65%, levofloxacin 39%, fosfomycin 3%, nitrofurantoin 2%, trimethoprim/sulfamethoxazole 72% and Piperacillin/Tazobactam 41%.
Conclusions: Our results showed that ceftazidime / avibactam, carbapenems, nitrofurantoin and fosfomycin may be among the first line treatment options in the empirical therapy. In selected patients, CAZ/AVI could be an option for the treatment of UTI caused by ESBL producing E.coli which may reduce the use of carbapenems. J Microbiol Infect Dis 2019; 9(2):112-115.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Estelle Caine
Articles by Ozlem Koyuncu Ozyurt
Articles by Gozde Ongut
Articles by Kubra Kasaroglu
Articles by Emre Yıldız
Articles by Dilara Ogunc
Articles by Filiz Gunseren
Articles by Dilek Colak
Articles by Ozge Turhan
Articles by Betil Ozhak
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Estelle Caine, Ozlem Koyuncu Ozyurt, Gozde Ongut, Kubra Kasaroglu, Emre Yıldız, Dilara Ogunc, Filiz Gunseren, Dilek Colak, Ozge Turhan, Betil Ozhak. In Vitro Activities of Ceftazidime-avibactam and Comparator Antimicrobial Agents Tested against ESBL Producing Urinary E. coli Isolates. J Microbiol Infect Dis. 2019; 9(3): 112-115 . doi:10.5799/jmid.614195

Web Style

Estelle Caine, Ozlem Koyuncu Ozyurt, Gozde Ongut, Kubra Kasaroglu, Emre Yıldız, Dilara Ogunc, Filiz Gunseren, Dilek Colak, Ozge Turhan, Betil Ozhak. In Vitro Activities of Ceftazidime-avibactam and Comparator Antimicrobial Agents Tested against ESBL Producing Urinary E. coli Isolates. https://www.jmidonline.org/?mno=302657025 [Access: November 22, 2024]. doi:10.5799/jmid.614195

AMA (American Medical Association) Style

Estelle Caine, Ozlem Koyuncu Ozyurt, Gozde Ongut, Kubra Kasaroglu, Emre Yıldız, Dilara Ogunc, Filiz Gunseren, Dilek Colak, Ozge Turhan, Betil Ozhak. In Vitro Activities of Ceftazidime-avibactam and Comparator Antimicrobial Agents Tested against ESBL Producing Urinary E. coli Isolates. J Microbiol Infect Dis. 2019; 9(3): 112-115 . doi:10.5799/jmid.614195


Vancouver/ICMJE Style

Estelle Caine, Ozlem Koyuncu Ozyurt, Gozde Ongut, Kubra Kasaroglu, Emre Yıldız, Dilara Ogunc, Filiz Gunseren, Dilek Colak, Ozge Turhan, Betil Ozhak. In Vitro Activities of Ceftazidime-avibactam and Comparator Antimicrobial Agents Tested against ESBL Producing Urinary E. coli Isolates. J Microbiol Infect Dis. (2019), [cited November 22, 2024]; 9(3): 112-115 . doi:10.5799/jmid.614195


Harvard Style

Estelle Caine, Ozlem Koyuncu Ozyurt, Gozde Ongut, Kubra Kasaroglu, Emre Yıldız, Dilara Ogunc, Filiz Gunseren, Dilek Colak, Ozge Turhan, Betil Ozhak (2019) In Vitro Activities of Ceftazidime-avibactam and Comparator Antimicrobial Agents Tested against ESBL Producing Urinary E. coli Isolates. J Microbiol Infect Dis, 9 (3), 112-115 . doi:10.5799/jmid.614195


Turabian Style

Estelle Caine, Ozlem Koyuncu Ozyurt, Gozde Ongut, Kubra Kasaroglu, Emre Yıldız, Dilara Ogunc, Filiz Gunseren, Dilek Colak, Ozge Turhan, Betil Ozhak. 2019. In Vitro Activities of Ceftazidime-avibactam and Comparator Antimicrobial Agents Tested against ESBL Producing Urinary E. coli Isolates. Journal of Microbiology and Infectious Diseases, 9 (3), 112-115 . doi:10.5799/jmid.614195


Chicago Style

Estelle Caine, Ozlem Koyuncu Ozyurt, Gozde Ongut, Kubra Kasaroglu, Emre Yıldız, Dilara Ogunc, Filiz Gunseren, Dilek Colak, Ozge Turhan, Betil Ozhak. "In Vitro Activities of Ceftazidime-avibactam and Comparator Antimicrobial Agents Tested against ESBL Producing Urinary E. coli Isolates." Journal of Microbiology and Infectious Diseases 9 (2019), 112-115 . doi:10.5799/jmid.614195


MLA (The Modern Language Association) Style

Estelle Caine, Ozlem Koyuncu Ozyurt, Gozde Ongut, Kubra Kasaroglu, Emre Yıldız, Dilara Ogunc, Filiz Gunseren, Dilek Colak, Ozge Turhan, Betil Ozhak. "In Vitro Activities of Ceftazidime-avibactam and Comparator Antimicrobial Agents Tested against ESBL Producing Urinary E. coli Isolates." Journal of Microbiology and Infectious Diseases 9.3 (2019), 112-115 . Print. doi:10.5799/jmid.614195


APA (American Psychological Association) Style

Estelle Caine, Ozlem Koyuncu Ozyurt, Gozde Ongut, Kubra Kasaroglu, Emre Yıldız, Dilara Ogunc, Filiz Gunseren, Dilek Colak, Ozge Turhan, Betil Ozhak (2019) In Vitro Activities of Ceftazidime-avibactam and Comparator Antimicrobial Agents Tested against ESBL Producing Urinary E. coli Isolates. Journal of Microbiology and Infectious Diseases, 9 (3), 112-115 . doi:10.5799/jmid.614195


Author LoginReviewer LoginAbout PublisherOpen Access PolicyEditorial PoliciesPeer Review PolicyPublication Ethics and Publication Malpractice StatementConflict of Interest PolicyPlagiarism PolicyProtection of Research Participants (Statement On Human And Animal Rights)Privacy PolicyCorrections, Retractions & Expressions of ConcernSelf-Archiving PoliciesDigital Archiving & Preservation PoliciesStatement of Informed ConsentAdvertising PolicyTerms of UseLicense InformationCopyright Information

About Journal of Microbiology and Infectious Diseases

Journal of Microbiology and Infectious Diseases (JMID) is an international "peer review" journal in microbiology, infectious diseases, virology, ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information

All correspondence should be addressed to:

Prof. Ibrahim Eldaghayes

Editor-in-Chief

Journal of Microbiology and Infectious Diseases

Department of Microbiology and Parasitology 

Faculty of Veterinary Medicine

University of Tripoli

P.O. Box 13662, Tripoli, Libya